Related Experiment Video
Updated: Oct 1, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease
Martina Gabrielli1, Ilaria Prada1, Pooja Joshi1
1CNR Institute of Neuroscience, Vedano al Lambro, MB 20854, Italy.
Abstract:
Synaptic dysfunction is an early mechanism in Alzheimer's disease that involves progressively larger areas of the brain over time. However, how it starts and propagates is unknown. Here we show that amyloid-β released by microglia in association with large extracellular vesicles (Aβ-EVs) alters dendritic spine morphology in vitro, at the site of neuron interaction, and impairs synaptic plasticity both in vitro and in vivo in the entorhinal cortex-dentate gyrus circuitry. One hour after Aβ-EV injection into the mouse entorhinal cortex, long-term potentiation was impaired in the entorhinal cortex but not in the dentate gyrus, its main target region, while 24 h later it was also impaired in the dentate gyrus, revealing a spreading of long-term potentiation deficit between the two regions. Similar results were obtained upon injection of extracellular vesicles carrying Aβ naturally secreted by CHO7PA2 cells, while neither Aβ42 alone nor inflammatory extracellular vesicles devoid of Aβ were able to propagate long-term potentiation impairment. Using optical tweezers combined to time-lapse imaging to study Aβ-EV-neuron interaction, we show that Aβ-EVs move anterogradely at the axon surface and that their motion can be blocked through annexin-V coating. Importantly, when Aβ-EV motility was inhibited, no propagation of long-term potentiation deficit occurred along the entorhinal-hippocampal circuit, implicating large extracellular vesicle motion at the neuron surface in the spreading of long-term potentiation impairment. Our data indicate the involvement of large microglial extracellular vesicles in the rise and propagation of early synaptic dysfunction in Alzheimer's disease and suggest a new mechanism controlling the diffusion of large extracellular vesicles and their pathogenic signals in the brain parenchyma, paving the way for novel therapeutic strategies to delay the disease.
Insights
Microglia-released amyloid-beta extracellular vesicles (Aβ-EVs) drive early Alzheimer's synaptic dysfunction. Their movement along neurons spreads impairments, offering new therapeutic targets for Alzheimer's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Alzheimer's Disease Research
Background:
- Synaptic dysfunction is an early Alzheimer's disease (AD) hallmark, but its initiation and spread remain unclear.
- Microglial dysfunction and amyloid-beta (Aβ) accumulation are key in AD pathogenesis.
Purpose of the Study:
- To investigate the role of microglial extracellular vesicles (EVs) carrying Aβ in initiating and propagating synaptic dysfunction in Alzheimer's disease.
- To elucidate the mechanism by which Aβ-EVs spread synaptic impairments within neural circuits.
Main Methods:
- In vitro and in vivo studies using mouse models.
- Amyloid-beta extracellular vesicle (Aβ-EV) injection into the mouse entorhinal cortex.
- Assessment of long-term potentiation (LTP) in the entorhinal cortex-dentate gyrus circuitry.
- Optical tweezers and time-lapse imaging to track Aβ-EV-neuron interactions.
- Inhibition of Aβ-EV motility using annexin-V coating.
Main Results:
- Aβ-EVs altered dendritic spine morphology in vitro and impaired synaptic plasticity (LTP) both in vitro and in vivo.
- LTP deficits spread from the entorhinal cortex to the dentate gyrus within 24 hours post-injection.
- Aβ-EVs exhibited anterograde motion along neuronal axons, and inhibiting this motility prevented LTP deficit propagation.
- Neither Aβ42 alone nor non-amyloid inflammatory EVs caused similar propagation of synaptic impairment.
Conclusions:
- Large microglial extracellular vesicles carrying amyloid-beta are implicated in the onset and spread of early synaptic dysfunction in Alzheimer's disease.
- The anterograde motility of Aβ-EVs along neuronal surfaces is a critical mechanism for the propagation of synaptic impairments.
- Targeting Aβ-EVs and their movement presents a novel therapeutic strategy to delay Alzheimer's disease progression.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

